{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:03:40Z","timestamp":1792181020912,"version":"4.4.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Mach Intell"],"DOI":"10.1038\/s42256-021-00408-w","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T17:03:17Z","timestamp":1636650197000},"page":"962-972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Out-of-distribution generalization from labelled and unlabelled gene expression data for drug response prediction"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0515-9267","authenticated-orcid":false,"given":"Hossein","family":"Sharifi-Noghabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-1787","authenticated-orcid":false,"given":"Parsa Alamzadeh","family":"Harjandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Zolotareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin C.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jamaoncol.2018.1660","volume":"4","author":"J Marquart","year":"2018","unstructured":"Marquart, J., Chen, E. Y. & Prasad, V. Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology. JAMA Oncol. 4, 1093\u20131098 (2018).","journal-title":"JAMA Oncol."},{"key":"408_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1200\/JCO.18.02037","volume":"37","author":"SK Pal","year":"2019","unstructured":"Pal, S. K. et al. Clinical cancer advances 2019: annual report on progress against cancer from the American society of clinical oncology. J. Clin. Oncol. 37, 834\u2013849 (2019).","journal-title":"J. Clin. Oncol."},{"key":"408_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.3954","volume":"21","author":"H Gao","year":"2015","unstructured":"Gao, H. et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat. Med. 21, 1318\u20131325 (2015).","journal-title":"Nat. Med."},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","volume":"483","author":"MJ Garnett","year":"2012","unstructured":"Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570\u2013575 (2012).","journal-title":"Nature"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","volume":"154","author":"A Basu","year":"2013","unstructured":"Basu, A. et al. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell 154, 1151\u20131161 (2013).","journal-title":"Cell"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","volume":"5","author":"B Seashore-Ludlow","year":"2015","unstructured":"Seashore-Ludlow, B. et al. Harnessing connectivity in a large-scale small-molecule sensitivity dataset. Cancer Discov. 5, 1210\u20131223 (2015).","journal-title":"Cancer Discov."},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nbt.3080","volume":"33","author":"C Klijn","year":"2015","unstructured":"Klijn, C. et al. A comprehensive transcriptional portrait of human cancer cell lines. Nat. Biotechnol. 33, 306\u2013312 (2015).","journal-title":"Nat. Biotechnol."},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio, F. et al. A landscape of pharmacogenomic interactions in cancer. Cell 166, 740\u2013754 (2016).","journal-title":"Cell"},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature17987","volume":"533","author":"PM Haverty","year":"2016","unstructured":"Haverty, P. M. et al. Reproducible pharmacogenomic profiling of cancer cell line panels. Nature 533, 333\u2013337 (2016).","journal-title":"Nature"},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"i510","DOI":"10.1093\/bioinformatics\/btz372","volume":"35","author":"S Mourragui","year":"2019","unstructured":"Mourragui, S., Loog, M., van de Wiel, M. A., Reinders, M. J. T. & Wessels, L. F. A. PRECISE: a domain adaptation approach to transfer predictors of drug response from pre-clinical models to tumors. Bioinformatics 35, i510\u2013i519 (2019).","journal-title":"Bioinformatics"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"i380","DOI":"10.1093\/bioinformatics\/btaa442","volume":"36","author":"H Sharifi-Noghabi","year":"2020","unstructured":"Sharifi-Noghabi, H., Peng, S., Zolotareva, O., Collins, C. C. & Ester, M. AITL: Adversarial Inductive Transfer Learning with input and output space adaptation for pharmacogenomics. Bioinformatics 36, i380\u2013i388 (2020).","journal-title":"Bioinformatics"},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature12831","volume":"504","author":"B Haibe-Kains","year":"2013","unstructured":"Haibe-Kains, B. et al. Inconsistency in large pharmacogenomic studies. Nature 504, 389\u2013393 (2013).","journal-title":"Nature"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1038\/nature20171","volume":"540","author":"JP Mpindi","year":"2016","unstructured":"Mpindi, J. P. et al. Consistency in drug response profiling. Nature 540, E5\u2013E6 (2016).","journal-title":"Nature"},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature19838","volume":"540","author":"P Geeleher","year":"2016","unstructured":"Geeleher, P., Gamazon, E. R., Seoighe, C., Cox, N. J. & Huang, R. S. Consistency in large pharmacogenomic studies. Nature 540, E1\u2013E2 (2016).","journal-title":"Nature"},{"key":"408_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1109\/TKDE.2009.191","volume":"22","author":"SJ Pan","year":"2010","unstructured":"Pan, S. J. & Yang, Q. A survey on transfer learning. IEEE Trans. Knowl. Data Eng. 22, 1345\u20131359 (2010).","journal-title":"IEEE Trans. Knowl. Data Eng."},{"key":"408_CR17","unstructured":"Neyshabur, B., Sedghi, H. & Zhang, C. What is being transferred in transfer learning? In 34th Conference on Neural Information Processing Systems (NeurIPS, 2020)."},{"key":"408_CR18","unstructured":"Raghu, M. et al. Transfusion: understanding transfer learning for medical imaging. In 33rd Conference on Neural Information Processing System (eds, Wallach, H. et al.) 3347\u20133357 (Curran Associates, 2019)."},{"key":"408_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s42256-020-00233-7","volume":"2","author":"J Hu","year":"2020","unstructured":"Hu, J. et al. Iterative transfer learning with neural network for clustering and cell type classification in single-cell RNA-seq analysis. Nat. Mach. Intell. 2, 607\u2013618 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"408_CR20","doi-asserted-by":"publisher","first-page":"i501","DOI":"10.1093\/bioinformatics\/btz318","volume":"35","author":"H Sharifi-Noghabi","year":"2019","unstructured":"Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C. & Ester, M. MOLI: multi-omics late integration with deep neural networks for drug response prediction. Bioinformatics 35, i501\u2013i509 (2019).","journal-title":"Bioinformatics"},{"key":"408_CR21","doi-asserted-by":"crossref","unstructured":"Snow, O. et al. Interpretable Drug Response Prediction using a Knowledge-based Neural Network. In Proc. 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining (2021).","DOI":"10.1145\/3447548.3467212"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","volume":"38","author":"BM Kuenzi","year":"2020","unstructured":"Kuenzi, B. M. et al. Predicting drug response and synergy using a deep learning model of human cancer cells. Cancer Cell 38, 672\u2013684.e6 (2020).","journal-title":"Cancer Cell"},{"key":"408_CR23","doi-asserted-by":"crossref","unstructured":"Mourragui, S. et al. Predicting clinical drug response from model systems by non-linear subspace-based transfer learning. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.06.29.177139v3 (2020).","DOI":"10.1101\/2020.06.29.177139"},{"key":"408_CR24","doi-asserted-by":"crossref","unstructured":"Ma, J. et al. Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients. Nat. Cancer 2, 233\u2013244 (2021).","DOI":"10.1038\/s43018-020-00169-2"},{"key":"408_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74921-0","volume":"10","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y. et al. Ensemble transfer learning for the prediction of anti-cancer drug response. Sci. Rep. 10, 18040 (2020).","journal-title":"Sci. Rep."},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"aba1862","DOI":"10.1126\/sciadv.aba1862","volume":"6","author":"M Salvadores","year":"2020","unstructured":"Salvadores, M., Fuster-Tormo, F. & Supek, F. Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns. Sci. Adv. 6, aba1862 (2020).","journal-title":"Sci. Adv."},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cels.2020.04.007","volume":"10","author":"H Najgebauer","year":"2020","unstructured":"Najgebauer, H. et al. CELLector: genomics-guided selection of cancer in vitro models. Cell Syst. 10, 424\u2013432.e6 (2020).","journal-title":"Cell Syst."},{"key":"408_CR28","doi-asserted-by":"crossref","unstructured":"Peres da Silva, R., Suphavilai, C. & Nagarajan, N. TUGDA: task uncertainty guided domain adaptation for robust generalization of cancer drug response prediction from in vitro to in vivo settings. Bioinformatics 37, i76\u2013i83 (2021).","DOI":"10.1093\/bioinformatics\/btab299"},{"key":"408_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20294-x","volume":"12","author":"A Warren","year":"2021","unstructured":"Warren, A. et al. Global computational alignment of tumor and cell line transcriptional profiles. Nat. Commun. 12, 22 (2021).","journal-title":"Nat. Commun."},{"key":"408_CR30","unstructured":"Gulrajani, I. & Lopez-Paz, D. In search of lost domain generalization. In International Conference on Learning Representations (2021)."},{"key":"408_CR31","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Generalizing to unseen domains: a survey on domain generalization. In Proc. Thirtieth International Joint Conference on Artificial Intelligence (2021).","DOI":"10.24963\/ijcai.2021\/628"},{"key":"408_CR32","unstructured":"Zhou, K., Liu, Z., Qiao, Y., Xiang, T. & Loy, C. C. Domain generalization: a survey. Preprint at https:\/\/arxiv.org\/abs\/2103.02503 (2021)."},{"key":"408_CR33","doi-asserted-by":"publisher","unstructured":"Zhang, H. et al. An empirical framework for domain generalization in clinical settings. In Proc. Conference on Health, Inference, and Learning (ACM, 2021); https:\/\/doi.org\/10.1145\/3450439.3451878","DOI":"10.1145\/3450439.3451878"},{"key":"408_CR34","unstructured":"Zhao, S., Gong, M., Liu, T., Fu, H. & Tao, D. Domain generalization via entropy regularization. In 33rd Conference on Neural Information Processing Systems (NeurIPS, 2020)."},{"key":"408_CR35","doi-asserted-by":"crossref","unstructured":"Wang, Z., Loog, M. & van Gemert, J. Respecting domain relations: hypothesis invariance for domain generalization. In 2020 25th International Conference on Pattern Recognition 9756\u20139763 (ICPR, 2021).","DOI":"10.1109\/ICPR48806.2021.9412797"},{"key":"408_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"Cancer Genome Atlas Research Networ","year":"2013","unstructured":"Cancer Genome Atlas Research Network et al. The cancer genome atlas pan-cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"408_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz, L. H. et al. RECIST 1.1\u2014update and clarification: from the RECIST committee. Eur. J. Cancer 62, 132\u2013137 (2016).","journal-title":"Eur. J. Cancer"},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jama.2011.593","volume":"305","author":"C Hatzis","year":"2011","unstructured":"Hatzis, C. et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305, 1873\u20131881 (2011).","journal-title":"JAMA"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/bioinformatics\/btw344","volume":"32","author":"Z Ding","year":"2016","unstructured":"Ding, Z., Zu, S. & Gu, J. Evaluating the molecule-based prediction of clinical drug responses in cancer. Bioinformatics 32, 2891\u20132895 (2016).","journal-title":"Bioinformatics"},{"key":"408_CR40","unstructured":"Tarvainen, A. & Valpola, H. Mean teachers are better role models: weight-averaged consistency targets improve semi-supervised deep learning results. In 31st Conference on Neural Information Processing Systems (2017)."},{"key":"408_CR41","unstructured":"Yang, Y. & Xu, Z. Rethinking the value of labels for improving class-imbalanced learning. In Conference on Neural Information Processing Systems (2020)."},{"key":"408_CR42","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1101\/gr.221077.117","volume":"27","author":"P Geeleher","year":"2017","unstructured":"Geeleher, P. et al. Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies. Genome Res. 27, 1743\u20131751 (2017).","journal-title":"Genome Res."},{"key":"408_CR43","doi-asserted-by":"publisher","unstructured":"Noghabi, H. S. et al. Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models. Briefings Bioinformatics https:\/\/doi.org\/10.1093\/bib\/bbab294 (2021).","DOI":"10.1093\/bib\/bbab294"},{"key":"408_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s00066-017-1126-9","volume":"193","author":"W Renner","year":"2017","unstructured":"Renner, W., Langsenlehner, U., Krenn-Pilko, S., Eder, P. & Langsenlehner, T. BCL2 genotypes and prostate cancer survival. Strahlenther. Onkol. 193, 466\u2013471 (2017).","journal-title":"Strahlenther. Onkol."},{"key":"408_CR45","first-page":"49","volume":"107","author":"KS Chaudhary","year":"1999","unstructured":"Chaudhary, K. S., Abel, P. D. & Lalani, E. N. Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention. Environ. Health Perspect. 107, 49\u201357 (1999).","journal-title":"Environ. Health Perspect."},{"key":"408_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/path.1711770306","volume":"177","author":"F Paraf","year":"1995","unstructured":"Paraf, F., Gogusev, J., Chr\u00e9tien, Y. & Droz, D. Expression of Bcl-2 oncoprotein in renal cell tumours. J. Pathol. 177, 247\u2013252 (1995).","journal-title":"J. Pathol."},{"key":"408_CR47","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1158\/1078-0432.CCR-06-3040","volume":"13","author":"KMR Bhat","year":"2007","unstructured":"Bhat, K. M. R. & Setaluri, V. Microtubule-associated proteins as targets in cancer chemotherapy. Clin. Cancer Res. 13, 2849\u20132854 (2007).","journal-title":"Clin. Cancer Res."},{"key":"408_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57670-y","volume":"10","author":"Z He","year":"2020","unstructured":"He, Z., Liu, H., Moch, H. & Simon, H.-U. Machine learning with autophagy-related proteins for discriminating renal cell carcinoma subtypes. Sci. Rep. 10, 720 (2020).","journal-title":"Sci. Rep."},{"key":"408_CR49","first-page":"15","volume":"2","author":"SK Martin","year":"2014","unstructured":"Martin, S. K., Kamelgarn, M. & Kyprianou, N. Cytoskeleton targeting value in prostate cancer treatment. Am. J. Clin. Exp. Urol. 2, 15\u201326 (2014).","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"408_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40170-016-0161-9","volume":"4","author":"RS Kelly","year":"2016","unstructured":"Kelly, R. S. et al. The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study. Cancer Metab. 4, 22 (2016).","journal-title":"Cancer Metab."},{"key":"408_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3892\/ol.2014.2118","volume":"8","author":"K Numakura","year":"2014","unstructured":"Numakura, K. et al. Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma. Oncol. Lett. 8, 464\u2013466 (2014).","journal-title":"Oncol. Lett."},{"key":"408_CR52","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-08-3760","volume":"69","author":"J-C Pignon","year":"2009","unstructured":"Pignon, J.-C. et al. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Res. 69, 2941\u20132949 (2009).","journal-title":"Cancer Res."},{"key":"408_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ejca.2006.11.007","volume":"43","author":"A Reid","year":"2007","unstructured":"Reid, A., Vidal, L., Shaw, H. & de Bono, J. Dual inhibition of ErbB1 (EGFR\/HER1) and ErbB2 (HER2\/neu). Eur. J. Cancer 43, 481\u2013489 (2007).","journal-title":"Eur. J. Cancer"},{"key":"408_CR54","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1200\/JCO.2008.18.8821","volume":"27","author":"MS Gordon","year":"2009","unstructured":"Gordon, M. S. et al. Phase II study of Erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317. J. Clin. Oncol. 27, 5788\u20135793 (2009).","journal-title":"J. Clin. Oncol."},{"key":"408_CR55","doi-asserted-by":"crossref","unstructured":"Chen, Y.-H. et al. No more discrimination: cross city adaptation of road scene segmenters. In Proc. IEEE International Conference on Computer Vision 1992\u20132001 (IEEE, 2017).","DOI":"10.1109\/ICCV.2017.220"},{"key":"408_CR56","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/nbt.2877","volume":"32","author":"JC Costello","year":"2014","unstructured":"Costello, J. C. et al. A community effort to assess and improve drug sensitivity prediction algorithms. Nat. Biotechnol. 32, 1202\u20131212 (2014).","journal-title":"Nat. Biotechnol."},{"key":"408_CR57","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Rensi, S., Wang, S. & Altman, R. B. DrugOrchestra: jointly predicting drug response, targets, and side effects via deep multi-task learning. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.11.17.385757v1 (2020).","DOI":"10.1101\/2020.11.17.385757"},{"key":"408_CR58","doi-asserted-by":"publisher","first-page":"51619","DOI":"10.18632\/oncotarget.10010","volume":"7","author":"N Pozdeyev","year":"2016","unstructured":"Pozdeyev, N. et al. Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies. Oncotarget 7, 51619\u201351625 (2016).","journal-title":"Oncotarget"},{"key":"408_CR59","unstructured":"Xia F, et al. A cross-study analysis of drug response prediction in cancer cell lines. Brief. Bioinform. (2021)."},{"key":"408_CR60","doi-asserted-by":"crossref","unstructured":"Sharifi-Noghabi, H., Liu, Y., Erho, N. & Shrestha, R. Deep genomic signature for early metastasis prediction in prostate cancer. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/276055v2 (2019).","DOI":"10.1101\/276055"},{"key":"408_CR61","doi-asserted-by":"publisher","first-page":"e0157484","DOI":"10.1371\/journal.pone.0157484","volume":"11","author":"A Torrente","year":"2016","unstructured":"Torrente, A. et al. Identification of cancer related genes using a comprehensive map of human gene expression. PLoS ONE 11, e0157484 (2016).","journal-title":"PLoS ONE"},{"key":"408_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-14-18","volume":"14","author":"C Villica\u00f1a","year":"2014","unstructured":"Villica\u00f1a, C., Cruz, G. & Zurita, M. The basal transcription machinery as a target for cancer therapy. Cancer Cell Int. 14, 18 (2014).","journal-title":"Cancer Cell Int."},{"key":"408_CR63","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","volume":"174","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 174, 1034\u20131035 (2018).","journal-title":"Cell"},{"key":"408_CR64","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1038\/s41375-020-0844-7","volume":"34","author":"SK Joshi","year":"2020","unstructured":"Joshi, S. K. et al. ERBB2\/HER2 mutations are transforming and therapeutically targetable in leukemia. Leukemia 34, 2798\u20132804 (2020).","journal-title":"Leukemia"},{"key":"408_CR65","doi-asserted-by":"crossref","unstructured":"Thomas, R. & Weihua, Z. Rethink of EGFR in cancer with its kinase independent function on board. Front. Oncol. 9, 800 (2019).","DOI":"10.3389\/fonc.2019.00800"},{"key":"408_CR66","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12288-020-01274-z","volume":"36","author":"S Nath","year":"2020","unstructured":"Nath, S. et al. The prognostic impact of epidermal growth factor receptor (EGFR) in patients with acute myeloid leukaemia. Indian J. Hematol. Blood Transfus. 36, 749\u2013753 (2020).","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"408_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/852748","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal, N. & Iqbal, N. Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Molecular Biol. Int. 2014, 1\u20139 (2014).","journal-title":"Molecular Biol. Int."},{"key":"408_CR68","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1001\/jamaoncol.2018.0775","volume":"4","author":"GD Goss","year":"2018","unstructured":"Goss, G. D. et al. Association of ERBB mutations with clinical outcomes of Afatinib- or Erlotinib-treated patients with lung squamous cell carcinoma: Secondary analysis of the LUX-lung 8 randomized clinical trial. JAMA Oncol. 4, 1189\u20131197 (2018).","journal-title":"JAMA Oncol."},{"key":"408_CR69","doi-asserted-by":"crossref","unstructured":"Mammoliti, A. et al. Orchestrating and sharing large multimodal data for transparent and reproducible research. Nature Communications volume 12, Article number: 5797 (2021).","DOI":"10.1101\/2020.09.18.303842"},{"key":"408_CR70","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/bioinformatics\/btv723","volume":"32","author":"P Smirnov","year":"2016","unstructured":"Smirnov, P. et al. PharmacoGx: an R package for analysis of large pharmacogenomic datasets. Bioinformatics 32, 1244\u20131246 (2016).","journal-title":"Bioinformatics"},{"key":"408_CR71","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt0816-888d","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Erratum: near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 888 (2016).","journal-title":"Nat. Biotechnol."},{"key":"408_CR72","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1021\/acs.molpharmaceut.9b00520","volume":"16","author":"M Manica","year":"2019","unstructured":"Manica, M. et al. Toward explainable anticancer compound sensitivity prediction via multimodal attention-based convolutional encoders. Mol. Pharm. 16, 4797\u20134806 (2019).","journal-title":"Mol. Pharm."},{"key":"408_CR73","doi-asserted-by":"crossref","unstructured":"Sun, B. & Saenko, K. Deep CORAL: correlation alignment for deep domain adaptation. In Computer Vision\u2014ECCV 2016 Workshops 443\u2013450 (Springer, 2016).","DOI":"10.1007\/978-3-319-49409-8_35"},{"key":"408_CR74","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1016\/j.celrep.2019.11.017","volume":"29","author":"T Sakellaropoulos","year":"2019","unstructured":"Sakellaropoulos, T. et al. A deep learning framework for predicting response to therapy in cancer. Cell Rep. 29, 3367\u20133373.e4 (2019).","journal-title":"Cell Rep."},{"key":"408_CR75","doi-asserted-by":"publisher","first-page":"D994","DOI":"10.1093\/nar\/gkx911","volume":"46","author":"P Smirnov","year":"2018","unstructured":"Smirnov, P. et al. PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies. Nucl. Acids Res. 46, D994\u2013D1002 (2018).","journal-title":"Nucl. Acids Res."},{"key":"408_CR76","doi-asserted-by":"publisher","unstructured":"Sarifi-Noghabi, H,. Harjandi, P. A., Zolotareva, O., Collins, C. C. & Ester, M. Velodrome: Out-of-Distribution Generalization from Labeled and Unlabeled Gene Expression Data for Drug Response Prediction (Zenodo, 2021); https:\/\/doi.org\/10.5281\/zenodo.4793442","DOI":"10.5281\/zenodo.4793442"},{"key":"408_CR77","doi-asserted-by":"publisher","unstructured":"Sharifi-Noghabi, H. Code Repository hosseinshn\/Velodrome: DOI (v1.0.0) (Zenodo, 2021); https:\/\/doi.org\/10.5281\/zenodo.5164625","DOI":"10.5281\/zenodo.5164625"}],"container-title":["Nature Machine Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00408-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T09:18:25Z","timestamp":1675847905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00408-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":77,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1038\/s42256-021-00408-w","relation":{},"ISSN":["2522-5839"],"issn-type":[{"value":"2522-5839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"31 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}